Pentwater Capital Management LP

Position in NUVL — Nuvalent, Inc.

CIK 1425851 NAPLES, FL

Position in NUVL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$0

New position

Shares Held

1,175,000

first reported quarter

Ownership

1.49%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Pentwater Capital Management LP holds $226,268,010 across 4 Biotechnology names. NUVL ranks #4 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	1,425,000	$189,140,250
2	TECH	BIO-TECHNE Corp	500,000	$35,325,000
3	SPTX	Seaport Therapeutics, Inc.	83,000	$1,802,760
4	NUVL	Nuvalent, Inc. This page	1,175,000	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	1,175,000	—	Shares	Sole	2026-08-14
No filing history on record for this holder in this stock.